Infertility after treatment of patients with Hodgkin's disease (HD) is considered as a side effect of alkylating agent containing chemotherapy regimens To investigate whether gonadal failure is related primarily to the toxic effect of chemotherapy or rather to the disease itself, we investigated the fertility status before the onset of treatment
Introduction
Treatment results in HD have improved tremendously over the last two decades. Depending on stage and risk factor profile, more than 80% of patients with HD will be cured with front-line treatment [1] . For these patients long term side effects of the treatment are of growing importance. In particular, these patients are at risk for secondary malignancies [2] [3] [4] , late pulmonary and cardiac complications [5] , psycho-social sequelae [6] , and infertility [7] Post treatment infertility presents a high psycho-social burden for young patients and limits their family planning. In general, the gonadal damage is attributed to toxic effects on the germinal epithelium caused by chemotherapy containing alkylating agents, especially cyclophosphamide and procarbazine In about 90% of patients treated with MOPP or MOPP-like regimens a reduced gonadal capacity has been reported [8] . Recovery rates one year to 15 years after the end of treatment with alkylating agents have been reported to be 2% to 25%.
However, in small series some authors found a reduced fertility of patients with HD prior to therapy indicating that HD associated factors contribute to infertility [9] [10] [11] [12] [13] .
We thus investigated the pre-treatment fertility status of 158 male patients enrolled into trials of the GHSG for early, intermediate, and advanced stage HD. Fertility status was correlated to clinical and biological features of the patients at the time of diagnosis.
Patients and methods
Fertility status was assessed in 158 male patients with first diagnosis of HD between 1992-1997 In a multicentric setting, pre-treatment patient data from 53 German and 6 Swiss centers were evaluated for this study All patients were enrolled into trial protocols HD 4-6 and HD (Table 1) To be eligible for entry into the protocols of the GHSG, patients had to have biopsy proven HD at diagnosis Histology was subsequently reviewed by an expert pathologist panel Eligibility criteria before study entry included adequate organ function as defined by a creatinine clearance > 60 ml/min, serum transaminases less than three times normal and bihrubin < 2 mg/dl. left ventricular ejection fraction >0 45, forced expiratory volume in first-second (FEV1) or diffusion capacity of carbon monoxide (DLCO) > 60 % of predicted, Karnofsky performance score of >60, and WBCs >3500/ul, hemoglobin level > 8 g/dl, platelets > 100.000/ul Patients were required to test negative for antibody against human immunodefiency virus and to be free of active infections All patients signed consent forms that were based on the Institutional Review Board Guidelines For the fertility analysis the age of the patients was restricted to < 55 years Participation in this study was not mandatory 
Semen analysis
After a sexual abstinence of at least three days semen samples were collected by masturbation in the participating centers or in associated andrological institutions All assays were evaluated for sperm volume, count, forward motility and morphological criteria of spermatozoa according to Nomenclature of pathologic patterns of the ejaculate followed Eliasson's classification of dyspermia (Table 2) [15] It defines single damages with a disturbance in one of these variables and combined, severe damages like an OAT-syndrome. as a disturbance of all three variables, or azoospermia with absence of spermatozoa in the ejaculate
Hormonal analysis
Follicle-stimulating hormone (FSH) and luteimsing hormone (LH) were measured by specific radio-immune-antibody assays (RIA), using commercial kits Normal laboratory ranges are as follows FSH 2-14 U/land LH 1-7 U/l [16]
Statistical analysis
The chi-square test and Fisher's exact test were used to investigate differences on proportions Correlations between the different variables were evaluated by both univanate and multivanate regression analysis using Microsoft software Excel for windows 5 0 and SPSS 6 0 Variables tested were age (< 30, > 30), risk groups (early, intermediate, advanced stage), histology (LP/NS vs MC/LD), hemoglobin ( < 14 g/dl. ^ 14 g/dl). systemic symptoms, erythrocyte sedimentation rate (ESR) (<30, >30), bulky disease, massive mediastinal mass, massive spleen involvement, and extranodal disease All variables found to have a /'-value of <0 05 in univanate evaluation were considered to be significant Multivanate analysis was conducted by stepwise regression analysis including all univanate significant vanables
Results

Patient characteristics
Patient characteristics are listed in Table 3 All patients were under 55 years of age (median 27.8, range 16-52). Of 158 observed patients, 19 patients were under 20 years of age (12%), 82 patients between 20 and 30 (52%), 46 patients between 30 and 40 years (29%) and 11 patients over 40 years of age (7%). Twenty patients (13%) had early stage HD, 63 patients (40%) intermediate stage, and 75 patients (47%) advanced stage according to the guidelines of the GHSG. Systemic symptoms were present in 67 of all patients (42%). ESR above 30 mm/h was found in 75 patients (48%). Bulky disease was present in 97 patients (61%), massive mediastinal mass in 38 patients (24%), massive spleen involvement in 21 patients (13%), and extranodal involvement in 27 patients (17%) 
Semen analysis
The median sperm concentration was 40 3 x 10 6 /ml (0-187), the median percentage of sperms with normal motility was 39.2% (0-95), and the median percentage of sperms with normal morphology was 35.4% (0-97) One hundred eleven patients (70%) had an inadequate semen quality before the onset of treatment. Severe damage was observed in 33 (21%) of the patients. Of these, 13 were azoospermic and 20 had an OAT-syndrome. Forty patients (25%) were found to have combined damages, with 20 patients presenting with OA, 3 patients with OT and 17 patients having AT. Single damages were found in 38 patients (24%). Only 47 (30%) patients showed a normal sperm analysis at the time of diagnosis (Table 4) .
Hormonal evaluation
Of all patients, FSH-levels were available from 139 and LH-levels from 113 patients. Figure 1 shows the FSHlevels according to the pre-treatment semen analysis. Only six patients showed pathological results with regard to FSH-levels > 13 U/l and even in the subgroup of the patients with severe damages only two patients presented with elevated FSH-values Comparable results were found in the evaluation of luteinising hormone with only 12 out of 113 patients showing abnormal results with LH-levels >9 U/l. Basal hormone levels were not affected by patients characteristics.
Predictive factors
In this analysis only the subgroups of patients were included either with severe damages of fertility, azoospermia and OAT-syndrome, or with an initially normal semen. Table 5 shows the results of the univanate and multivariate analysis. We found low hemoglobin, elevated ESR, massive mediastinal involvement, extranodal involvement, and risk groups being significantly predictive for a severe damage of fertility. Thus, advanced stage HD was associated with a higher probability of having decreased semen quality. Subsequently all univariate significant factors were included in a stepwise multivariate regression. In this multivariate analysis high ESR and risk groups remained significant for a severe dyspermia at the time of diagnosis. II (38) 6(31) 7(36) 13 (26) 9(25) 37 (46) 30 (33) II (28) 47 (30) Dyspermia n 1 (%)
26 (62) 13 (69) 12 (63) 36 (73) 26 (75) 43 (54) 62 (67) 28 (71) 111 (70)
Discussion
The following findings emerge from this analysis: 1) prior to treatment 70% of patients with HD showed abnormal semen quality, 2) 21% had severe damages (azoospermia or OAT-syndrome) indicating a severe pre-treatment subfertihty; 3) FSH-and LH-values were not associated with the extend of infertility; 4) significantly HD-related prognostic factors for severe damages were elevated ESR and advanced disease.
In our analysis the mean sperm concentration of all patients was 40.3 x 10 6 /ml (range 0-187 x 10 6 ), the mean percentage of sperms with normal motihty was 39 2% (range 0%-95%), and the mean percentage of sperms with normal morphology was 35.4% (range 0-97%). Compared to healthy controls we found a considerable decrease in fertility parameters. In a French population the mean sperm concentration for 1351 healthy men was two fold higher than in our series (98.8 x 10 6 /ml), the mean percentage of sperms with normal motihty was 66%, and the mean percentage of sperms with normal morphology was 61% [17] In a Finnish study of 238 normal men the mean sperm concentration was 133.9 x l0 6 /ml [18] . In our study 70% of the patients presented with a dyspermia at the time of diagnosis. Similar results were demonstrated in other studies (Table 6 ). Chapman et al found 16 of 37 patients (43%) with HD having inadequate sperm counts before the onset of treatment. Biopsies of the testes were taken from nine patients. Eight of these biopsies showed pathological changes up to sclerosis of the germinal epithelium [7] .
Physiologically elevated levels of FSH and LH are regarded as sensitive markers of the gonadal system. In our studies as shown in previous investigations pretherapeutic FSH and LH levels showed no specificity for the grade of dyspermia [12, 13] Even patients with azoospermia or OAT-syndrome often presented with normal hormon levels. Although the underlying mechanism for these findings are yet unknown our results point at a complex damage of fertility including direct damages of the germinal epithelium and disturbances of the hypothalamic-hypophysial axis. Furthermore FSH and LH are demonstrated not to be helpful in detecting patients with inadequate semen quality. For men semen analysis has to be performed for definite evaluation of fertility.
Beside HD decreased fertility rates were identified at the time of diagnosis also in patients with non-Hodgkin lymphoma, testicular cancer and other neoplasms [19] [20] [21] [22] [23] . Assuming that HD itself, as a systemic disease, induces the dyspermia several changes going along with the course of disease were discussed to be responsible. Systemic symptoms, especially fever were described to be associated with higher rates of infertility [24] . In our study, ESR and risk group remained significant in the multivariate analysis. Interestingly, advanced disease was associated with a higher rate of gonadal damages supporting the hypothesis that the extend of HD itself is responsible for the fertility impairment. In addition, elevated ESR is an important prognostic factor in HD. The influence of ESR might be associated with the influence of different cytokines on fertility that has been reported by many authors in recent publications [25] [26] [27] [28] [29] [30] Since HD is a biologically active disease several cytokines have attracted interest as possible mechanism contributing to infertility. Interleukines IL-1, IL-6, TNF-a, and soluble interleukin receptor sR IL-2 and sR IL-6 are influencing spermatogenesis and fertility parameters.
If HD itself induces the observed changes a successful therapy of HD may lead to recovery of fertility, but only if the chemotherapy regimen does not contain no gonadal toxic drugs In smaller series different recovery rates of fertility after chemotherapy for HD are reported [7, 8, [32] [33] [34] [35] . Only with ABVD alone a high recovery rate after treatment was observed. This is important since patients with HD are mainly of younger age and family planning may not be finished with the onset of disease. Furthermore, reproductive function is reduced in a substantial number of patients at the time of diagnosis compromising the possibility for spontaneous fertilisation and the opportunity for cryopreservation of sperm prior to treatment [14] . Future effort should concentrate on identifying new potent chemotherapy regimens with the ability to preserve gonadal function. Further investigations have to be performed to clarify
